Vanguard Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.02B | Buy |
|
|||||
|
2025
Q1 | $11.7B | Buy |
|
|||||
|
2024
Q4 | $10.7B | Buy |
|
|||||
|
2024
Q3 | $9.76B | Buy |
|
|||||
|
2024
Q2 | $7.75B | Buy |
|
|||||
|
2024
Q1 | $10.1B | Sell |
|
|||||
|
2023
Q4 | $10.2B | Sell |
|
|||||
|
2023
Q3 | $11.6B | Sell |
|
|||||
|
2023
Q2 | $13B | Sell |
|
|||||
|
2023
Q1 | $14.2B | Buy |
|
|||||
|
2022
Q4 | $14.6B | Buy |
|
|||||
|
2022
Q3 | $14.2B | Buy |
|
|||||
|
2022
Q2 | $15.2B | Sell |
|
|||||
|
2022
Q1 | $14.5B | Sell |
|
|||||
|
2021
Q4 | $12.5B | Buy |
|
|||||
|
2021
Q3 | $11.8B | Buy |
|
|||||
|
2021
Q2 | $13.2B | Buy |
|
|||||
|
2021
Q1 | $12.4B | Sell |
|
|||||
|
2020
Q4 | $12.4B | Sell |
|
|||||
|
2020
Q3 | $12.1B | Sell |
|
|||||
|
2020
Q2 | $12B | Buy |
|
|||||
|
2020
Q1 | $11.1B | Buy |
|
|||||
|
2019
Q4 | $12.5B | Buy |
|
|||||
|
2019
Q3 | $6.82B | Buy |
|
|||||
|
2019
Q2 | $6.08B | Buy |
|
|||||
|
2019
Q1 | $6.32B | Buy |
|
|||||
|
2018
Q4 | $6.85B | Buy |
|
|||||
|
2018
Q3 | $7.97B | Buy |
|
|||||
|
2018
Q2 | $7.04B | Buy |
|
|||||
|
2018
Q1 | $7.92B | Buy |
|
|||||
|
2017
Q4 | $7.57B | Buy |
|
|||||
|
2017
Q3 | $7.76B | Buy |
|
|||||
|
2017
Q2 | $6.61B | Buy |
|
|||||
|
2017
Q1 | $6.43B | Buy |
|
|||||
|
2016
Q4 | $6.71B | Buy |
|
|||||
|
2016
Q3 | $6.08B | Buy |
|
|||||
|
2016
Q2 | $8.06B | Buy |
|
|||||
|
2016
Q1 | $6.77B | Buy |
|
|||||
|
2015
Q4 | $6.95B | Buy |
|
|||||
|
2015
Q3 | $5.84B | Buy |
|
|||||
|
2015
Q2 | $6.47B | Buy |
|
|||||
|
2015
Q1 | $6.1B | Buy |
|
|||||
|
2014
Q4 | $5.39B | Buy |
|
|||||
|
2014
Q3 | $4.41B | Buy |
|
|||||
|
2014
Q2 | $4.08B | Buy |
|
|||||
|
2014
Q1 | $4.27B | Buy |
|
|||||
|
2013
Q4 | $4.25B | Buy |
|
|||||
|
2013
Q3 | $3.64B | Buy |
|
|||||
|
2013
Q2 | $3.43B | Buy |
|